NYMX Market Cap History
Below is a table of the NYMX market cap history going back to 8/13/2010:

Date NYMX Market Cap
8/13/2010136.83M
12/31/2010229.32M
12/31/2011271.20M
12/31/2012230.31M
5/15/2013172.99M
11/14/2013229.91M
12/31/2013210.46M
12/31/201414.35M
12/31/2015141.00M
12/31/2016131.14M
12/31/2017186.05M
12/31/201884.73M
3/23/201519.39M
12/31/2019156.68M
12/31/2020193.34M

Also see: NYMX Shares Outstanding History
and NYMX YTD Return
NYMX Historical Market Cap:
+3.38% CAGR
NYMX Historical Market Cap: +3.38% CAGR

Mouse over chart for data details
8/13/2010 ...12/31/2020
Nymox Pharmaceutical is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia and the treatment of low-grade localized prostate cancer. Co. has developed and markets NicAlert™ and TobacAlert™, which are test strips for determining whether a person is using tobacco products (NicAlert™) or has been exposed to second-hand smoke (TobacAlert™). Both NicAlert™ and TobacAlert™ employ the patented technology of Co.'s subsidiary, Serex, Inc., to provide a read-out of levels of cotinine, a by-product of the body's breakdown of nicotine and generally regarded as the indicator of tobacco exposure for smokers and nonsmokers. We show 15 historical shares outstanding datapoints in our NYMX shares outstanding history coverage, used to compute NYMX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NYMX market cap history over the course of time is important for investors interested in comparing NYMX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NYMX versus a peer is one thing; comparing NYMX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NYMX can fluctuate over the course of history. With this page we aim to empower investors researching NYMX by allowing them to research the NYMX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NYMX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nymox Pharmaceutical (NYMX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

OBLN Market Cap History
OCGN Market Cap History
OCUL Market Cap History
OCUP Market Cap History
OCX Market Cap History
ODT Market Cap History
OFIX Market Cap History
OGN Market Cap History
OHRP Market Cap History
OLMA Market Cap History
More Healthcare companies »

 

NYMX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.